25th Apr 2016 11:09
LONDON (Alliance News) - Akers Biosciences Inc Monday said it is shuffling its board, with Non-Executive Co-Chairman Thomas Knox to become the company's sole chairman.
Co-Founder and Executive Chairman Raymond Akers Jr will become co-founder and chief scientific director.
Akers appointed John Gormally as its chief executive officer in November.
"Having our recently appointed CEO focusing successfully on product commercialization and operations enables us to deploy the strengths of the board of directors more effectively; I am pleased that this allows Dr Akers to focus on accelerating the development of our pipeline of rapid diagnostic tests," said Chairman Thomas Knox in a statement.
Shares in Akers last closed at 113.50 pence and were untraded on Monday.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
AKR.L